SCHEMBL5499533

SCHEMBL5499533

CC(C=O)Cc1ccc(C(=O)O)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 12/20 0.54
KDM4E B2RXH2 4/20 0.53
L3MBTL1 Q9Y468 3/20 0.53
TSHR P16473 2/20 0.53
ALDH1A1 P00352 2/20 0.53
KMT2A Q03164 2/20 0.53
HIF1A Q16665 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
MEN1 O00255 1/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
PKM P14618 1/20 0.53
ALOX15 P16050 1/20 0.53
NFKB1 P19838 1/20 0.53
THPO P40225 1/20 0.53
BLM P54132 1/20 0.53
PMP22 Q01453 1/20 0.53
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3947896 0.83 P4HTM (0.61) P4HTMKDM4EL3MBTL1TSHRALDH1A1
SCHEMBL7897000 0.82 P4HTM (0.59) P4HTMKDM4EL3MBTL1TSHRALDH1A1
SCHEMBL5497689 0.76 TP53 (0.49) TSHRTP53CPB2
SCHEMBL5498501 0.75 TP53 (0.56) KDM4EL3MBTL1TSHRALDH1A1KMT2A
SCHEMBL29852428 0.75 KDM4E (0.52) P4HTMKDM4EL3MBTL1TSHRALDH1A1
SCHEMBL286868 0.74 KDM4E (0.69) P4HTMKDM4EL3MBTL1TSHRALDH1A1
SCHEMBL25355779 0.74 P4HTM (0.57) P4HTMKDM4EL3MBTL1TSHRALDH1A1
SCHEMBL26008291 0.74 P4HTM (0.57) P4HTMKDM4EL3MBTL1TSHRALDH1A1
SCHEMBL31303980 0.74 P4HTM (0.57) P4HTMKDM4EL3MBTL1TSHRALDH1A1
SCHEMBL6266472 0.73 TP53 (0.46) KDM4ETSHRKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1625123-A4 3-(2-AMINO-1-AZACYCLYL)-5-ARYL-1,2,4-OXADIAZOLES AS S1P RECEPTOR AGONISTS MERCK & CO INC (US) 2007-08-29 EP disclosed
EP-1670463-A2 3,5-ARYL, HETEROARYL OR CYCLOALKYL SUBSTITUTED-1,2,4-OXADIAZOLES AS S1P RECEPTOR AGONISTS Merck & Co., Inc. (US) 2006-06-21 EP disclosed
EP-1625123-A2 3-(2-AMINO-1-AZACYCLYL)-5-ARYL-1,2,4-OXADIAZOLES AS S1P RECEPTOR AGONISTS Merck & Co., Inc. (US) 2006-02-15 EP disclosed
WO-2005032465-A2 3,5-ARYL, HETEROARYL OR CYCLOALKYL SUBSTITUTED-1,2,4-OXADIAZOLES AS S1P RECEPTOR AGONISTS MERCK & CO., INC. (US) 2005-04-14 WO disclosed
WO-2004103279-A2 3-(2-AMINO-1-AZACYCLYL)-5-ARYL-1,2,4-OXADIAZOLES AS S1P RECEPTOR AGONISTS MERCK & CO., INC. (US) 2004-12-02 WO disclosed